valine has been researched along with incb-018424 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brower, V | 1 |
| Al-Ali, HK; Gopalakrishna, P; Hubert, K; Koehler, A; Lange, T; Monecke, A; Niederwieser, D; Siebolts, U; Wickenhauser, C | 1 |
| Garcia, KC; Hafer, M; Hitchcock, IS; Hubbard, SR; Kurre, R; Löchte, S; Moraga, I; Piehler, J; Poojari, C; Pulgar Prieto, KD; Richter, CP; Sharma, V; Stanly, TA; Tucker, JA; Vattulainen, I; Vuorio, J; Wilmes, S; Winkelmann, H | 1 |
3 other study(ies) available for valine and incb-018424
| Article | Year |
|---|---|
Myeloproliferative cancers: treatment prospects for rare diseases.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow Transplantation; Clinical Trials as Topic; Humans; Interferon-alpha; Janus Kinase 2; Leukemia, Myeloid; Mutation; Nitriles; Phenylalanine; Polyethylene Glycols; Pyrazoles; Pyrimidines; Rare Diseases; Recombinant Proteins; Valine | 2012 |
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib.
Topics: Amino Acid Substitution; Humans; Janus Kinase 2; Male; Middle Aged; Nitriles; Phenylalanine; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Remission Induction; Valine | 2015 |
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.
Topics: Amino Acid Substitution; Carcinogenesis; Cell Membrane; HeLa Cells; Humans; Janus Kinase 2; Ligands; Microscopy, Fluorescence; Models, Molecular; Mutation; Nitriles; Phenylalanine; Protein Multimerization; Pyrazoles; Pyrimidines; Receptors, Erythropoietin; Receptors, Somatotropin; Receptors, Thrombopoietin; Signal Transduction; Single Molecule Imaging; Valine | 2020 |